AI assistant
HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012
Jul 28, 2012
33572_dirs_2012-07-27_6fea5a7b-2aee-4e92-935f-58077bf6b8e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-25
Reporting Person: TANG KEVIN C (Director, 10% Owner)
Reporting Person: TANG CAPITAL MANAGEMENT LLC (Director, 10% Owner)
Reporting Person: TANG CAPITAL PARTNERS LP (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-25 | Common Stock | A | 9523810 | $0.525 | Acquired | 69960316 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 286950 | Indirect |
| Common Stock | 138841 | Direct |
Footnotes
F1: The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Mr. Tang disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F2: The securities are held by Kevin C. Tang as custodian for his minor children, as Trustee of the Tang Family Trust, and as Trustee of the Tang Advisors, LLC Profit Sharing Plan.
F3: 42,950 of these securities are held by Kevin C. Tang's IRA.